Matches in DBpedia 2016-04 for { <http://citation.dbpedia.org/hash/5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d> ?p ?o }
Showing triples 1 to 9 of
9
with 100 triples per page.
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d assign1 "Glaxo Group Limited".
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d country "US".
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d fdate "1986-11-17".
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d gdate "1987-09-22".
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d inventor "Coates IH, Bell JA, Humber DC, Ewan GB".
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d isCitedBy Ondansetron.
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d number "4695578".
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d status "patent".
- 5bc5669da0ad3fde598d48238b919852ee3363043f8b820e4a3298d7b721e01d title "1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances".